Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,568,673
  • Shares Outstanding, K 114,464
  • Annual Sales, $ 490,490 K
  • Annual Income, $ -58,220 K
  • 60-Month Beta 1.68
  • Price/Sales 10.93
  • Price/Cash Flow N/A
  • Price/Book 6.69
Trade TXG with:

Options Overview Details

View History
  • Implied Volatility 77.18% ( +4.77%)
  • Historical Volatility 63.50%
  • IV Percentile 16%
  • IV Rank 21.89%
  • IV High 124.19% on 06/13/22
  • IV Low 64.01% on 02/02/22
  • Put/Call Vol Ratio 0.24
  • Today's Volume 73
  • Volume Avg (30-Day) 274
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 6,149
  • Open Int (30-Day) 4,921

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.29
  • Number of Estimates 6
  • High Estimate -0.22
  • Low Estimate -0.39
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -81.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.28 +55.53%
on 12/28/22
49.46 -1.64%
on 01/23/23
+16.76 (+52.56%)
since 12/27/22
3-Month
25.69 +89.37%
on 10/28/22
49.46 -1.64%
on 01/23/23
+21.88 (+81.73%)
since 10/27/22
52-Week
23.81 +104.33%
on 10/24/22
100.00 -51.35%
on 02/02/22
-37.21 (-43.34%)
since 01/27/22

Most Recent Stories

More News
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023

/PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after...

TXG : 48.65 (+1.29%)
3 Medical Info Systems Stocks Braving Industry-wide Headwinds

Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.

TXG : 48.65 (+1.29%)
NXGN : 18.35 (-1.24%)
HCAT : 13.70 (+0.44%)
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will...

TXG : 48.65 (+1.29%)
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first...

TXG : 48.65 (+1.29%)
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the commercial...

TXG : 48.65 (+1.29%)
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates

10x Genomics (TXG) delivered earnings and revenue surprises of 17.78% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TXG : 48.65 (+1.29%)
CLOV : 1.2500 (+4.17%)
10x Genomics: Q3 Earnings Snapshot

10x Genomics: Q3 Earnings Snapshot

TXG : 48.65 (+1.29%)
10x Genomics Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2022. Recent Highlights Revenue was...

TXG : 48.65 (+1.29%)
10x Genomics to Host Investor Day on December 8, 2022

/PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will host an Investor Day on December 8, 2022 at the company's headquarters in Pleasanton, CA...

TXG : 48.65 (+1.29%)
Can Rising Visits Help Teladoc (TDOC) Beat on Earnings in Q3?

The third-quarter results of Teladoc (TDOC) are likely to reflect a rise in Access Fees and Visit Fee revenues.

HUM : 481.69 (-3.54%)
MD : 15.17 (-0.59%)
TDOC : 29.47 (+6.47%)
TXG : 48.65 (+1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 51.14
2nd Resistance Point 49.96
1st Resistance Point 49.30
Last Price 48.65
1st Support Level 47.47
2nd Support Level 46.29
3rd Support Level 45.63

See More

52-Week High 100.00
Fibonacci 61.8% 70.90
Fibonacci 50% 61.90
Fibonacci 38.2% 52.91
Last Price 48.65
52-Week Low 23.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar